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Hepatitis-A Virus
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and Uzochukwu Gospel Ukachukwu
Abstract
The review on antiviral anti-hepatitis A virus agents is warranted given the 
importance of hepatitis A virus (HAV) as a human pathogen. Novel antiviral 
drugs have been sourced from natural agents and developed into products for 
management of viral infections. The role of purified natural products in treat-
ment and as adjunctives in the management of HAV infections is clearly plausible. 
Treatments against Hepatitis A virus infection is currently limited. In this chap-
ter, the antiviral natural products against hepatitis-A virus (HAV), their sources 
as well as their treatment approach and their application have been discussed. 
The antiviral natural products could be sourced generally from plants, herbs 
and animals. These natural agents have been shown to demonstrate substantial 
antiviral activity against HAV and could target various stages of the viral life 
cycle, replication, assemblage, release, as well as targeting virus-host specific 
interactions.
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1. Introduction
The role of purified natural products in prophylaxis, palliative and curative 
treatment of myriad diseases of bacterial, fungal and viral origin cannot be overem-
phasized. Novel antiviral drugs have been sourced from natural agents and devel-
oped into products for prophylactic and therapeutic purposes [1]. These natural 
agents have been shown to demonstrate antiviral activity by interfering with viral 
life cycle, replication, assemblage, release, as well as targeting virus-host specific 
interactions [1]. Antiviral natural products can be sourced generally from plants or 
herbs, microbes, animals and humans. In this chapter, the antiviral natural products 
against hepatitis-A virus (HAV), their sources as well as their treatment approach 
and their application were adequately discussed.
2. Therapeutic anti-HAV natural products
Hepatitis A virus is among the pathogens that find their way into the human 
system through ingestion of food contaminated with them, and most of these 
food-borne viruses lack licensed antivirals. Vaccine development and immunization 
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against several viruses including hepatitis A virus lack preventive and efficient anti-
viral therapies, as they are often challenged by counter-production of viral escape 
mutants that evade the immune system [1]. Also, the development of efficient and 
low-cost vaccines for economically unprivileged countries will be difficult, includ-
ing countries with low prevalence where vaccine is recommended only for high-risk 
individuals [2]. Post-exposure of the human system to viral infections requires 
an efficient therapeutic approach to clear infections off the human system. It is 
imperative to develop effective antiviral therapeutic agents against these viruses, 
and interest in the employment of natural products as effective antiviral therapeutic 
agents has widely increased.
Flavonoids, polyphenols, saponin, proanthocyanins, polysaccharides, organic 
acids, proteins, polypeptides, and essential oils obtained from plant, animals or 
microorganisms can control and eradicate food-borne viral infections includ-
ing hepatitis A [3, 4]. Over the past two decades, much effort has been aimed at 
identifying natural products, mostly of plant origin, to control food-borne viruses. 
Extracts from natural plants potentially have several applications, not limited to 
increasing the safety of food products and enhancing their quality, but also to serve 
as natural antiviral agents. For instance, these extracts possess several natural com-
pounds that have been reported to demonstrate virucidal activity against surrogates 
of the human novovirus, a known food-borne virus [5]. In this section, we will 
discuss the antiviral therapeutic activities of several natural products and herbal 
medicines against hepatitis A viral infection.
2.1 Plant-based
2.1.1 Green tea extract
Green tea extract (GTE) is produced from the leaves of cultivated evergreen 
tea plant, Camellia sinensis L., of the family Theaceae [6]. It is rich in polyphenols 
and proanthocyanidins, and has been widely used to nutritionally enrich various 
food and beverages due to reports about its diverse health benefits such as pos-
sessing antioxidant, anti-inflammatory, and anti-carcinogenic properties [7–9]. 
Studies have revealed that GTE exhibits inhibitory properties against a wide 
variety of food-borne pathogens [10, 11]. Chemical composition of GTE includes 
mainly catechins, a group of flavonoids [12] that possess antimicrobial proper-
ties on a wide spectrum of Gram-positive and Gram-negative bacteria [11]. In a 
study, catechins such as epigallocatechin-3-gallate (EGCG) and epicatechin gallate 
(ECG), contained in GTE demonstrated the strongest antiviral properties [13], and 
also exhibited significant antiviral properties when encapsulated within chitosan 
electrosprayed microcapsules [14].
Recent in vitro study revealed that GTE demonstrated excellent antiviral activity 
against hepatitis A virus under controlled conditions of concentration, pH, tem-
perature and also time exposure. It was shown that 5 mg/ml GTE incubated with 
the viral suspension for 2 h at 37°C and pH of 7.2 observed that there was complete 
inactivation of the virus in the suspension [6]. Findings suggested that GTE antivi-
ral activity thrived better under increasing alkaline conditions. GTE has also been 
evaluated as a natural sanitizer of farm produce, demonstrating that HAV titers in 
lettuce and spinach were drastically reduced after 30 min treatment with 10 mg/
ml GTE. Hence GTE holds promise for food-borne viral infection control through 
disinfection of food produce before consumption. Although the antiviral mechanisms 
of GTE have not yet been elucidated, some extrapolations could be drawn from the 
action of EGCG on viruses as it is the chief constituent compound in GTE [14, 15]. 
EGCG has high affinity for viral surface proteins but binds nonspecifically to them. 
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Therefore it exhibits its antiviral activity against a wide variety of enveloped and 
non-enveloped viruses by interfering with viral attachment to cell membrane 
receptors upon binding to them; thus, HAV infection could be curbed by GTE via 
similar mechanism.
2.1.2 Grape seed extract
Grape seed extract (GSE), Vitis vinifera, is generally obtained as a by-product of 
the grape juice and wine industry during processing of grapes [16]. It is reported 
to possess diverse bioactive principles including anthocyanins, flavonoids, proan-
thocyanidins, polyphenols, procyanidins and resveratrol, a derivative of stilbene 
[17]. The antioxidative, anti-inflammatory, cardioprotective, hepatoprotective, 
neuroprotective, and antimicrobial properties of these compounds make the extract 
to exhibit impressive pharmacological and therapeutic benefits [18].
GSE demonstrates antimicrobial activity against many food-borne bacterial 
pathogens including Listeria monocytogenes, Staphylococcus aureus, methicillin-
resistant S. aureus (MRSA), Escherichia coli O157:H7, Salmonella enterica serovar 
Enteritidis, and S. typhimurium [19–21]. Moreover, studies have reported the 
antiviral activities of GSE against some food-borne viruses including hepatitis A 
virus (HAV), human norovirus surrogates (feline calicivirus (FCV-F9)) and murine 
norovirus (MNV-1) [22, 23]. Under simulated gastrointestinal conditions, GSE 
reduced the HAV titer to undetectable levels in a dose-dependent fashion at varied 
temperatures (room temperature, 37°C) and time not exceeding 24 h. Emphatically, 
2 mg/ml GSE drastically reduced HAV titer among other food-borne viruses to 
undetectable levels in intestinal fluid after 6 h.
However, this success may not be reproducible in the human system as the HAV 
strain, HM175, used during the study was a lab-adapted strain that was not sensitive 
to low pH as observed in the wild type strain. Again, some studies showed that GSE 
anti-HAV activity decreased in the presence of increasing concentrations of 0.02 
and 0.2% dried milk or lettuce extract, where a higher dose is required to inactivate 
viral replication [24]. This implies that proteins could interfere with GSE antivi-
ral activity and consequently decreases its effectiveness for treatments. Also, at 
concentrations ranging from 0.25 to 1 mg/ml GSE was said to diminish food-borne 
viral contamination levels on food produce (lettuce and peppers) without causing 
notable color changes on them. Therefore, GSE could be considered as a control 
measure for hepatitis A virus contamination on food produce before consumption, 
though may require a synergistic approach to combat persistent contamination of 
food produce.
The antiviral mechanisms of GSE are not yet well expounded. However, some 
studies suggest that resveratrol (RV), a nonflavonoid polyphenol found in grapes 
modulate some intracellular signaling pathways of the influenza virus [25]. In a 
study evaluating the effect of GSE on the adsorption and replicativity of HAV, it was 
revealed that treatment of the host cells with GSE prior to viral infection caused 
significant decline in HAV titer [26]. Post-viral infection of the host cells showed 
that HAV titers decreased insignificantly. This implies that GSE may have a moder-
ate antiviral effect on adsorption of HAV on the host cells but with less effect on its 
replication [26]. Likewise, GSE was reported to down-regulate the expression of 
HIV entry coreceptors, implying that GSE may interrupt the binding of the virus 
to the cell receptors and in turn prevent HIV entry into normal lymphocytes [27]. 
Presently, GSE appears not to cause any structural damage to the viral capsid of 
HAV, rather it is more likely to exert greater antiviral activity by potentially block-
ing the host cell receptors and consequently prevents viral entry, replication, and 
infection.
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2.1.3 Egyptian red sea seagrass extract
Seagrass is a critical part of the marine ecosystem and is generally distributed 
along the tropical and temperate coastal zones of the world [28]. It was said to be 
the only marine flowering plant that completes its lifecycle in sea water and often 
lives entirely submerged [29]. It is of ecological importance and is employed in 
folklore medicine for therapeutic purposes [30, 31]. The Egyptian Red Sea seagrass, 
Thalassodendron ciliatum, is said to be one of the longest and most common sea 
grasses along the Egyptian Red Sea. Its leaves are characterized by many ‘tannin 
cells’ more than in any other sea grass [32], which infers that it possesses a high 
phenolic content.
Compounds isolated from the sea grass crude extract have been shown to exhibit 
antioxidant and cytotoxic activities [28]. The crude extract demonstrated 100% 
inhibition of hepatitis A (HAV) and Herpes Simplex (HSV-1) viruses at 20 μg/
mL. The antiviral activity of the crude extract against HAV was lost by fraction-
ation, which could be explained by the synergistic action of several compounds in 
the crude extract [28]. Moreover, knowledge about the mechanism of anti-HAV 
activity of T. ciliatum has not yet been elucidated. Further studies are required to 
evaluate the toxicity of T. ciliatum on humans after consumption as food supple-
ment or on formulation as a therapeutic drug against HAV.
2.1.4 Essential oils
Essential oils (EOs) are aromatic oily liquids derived from plant materials 
such as flowers, buds, seeds, leaves, branches, bark, grass, wood, fruit, and roots. 
Production of essential oils is majorly by steam distillation or by other methods 
such as solvent-heat extraction, pressing, fermentation or enfleurage [33]. Chemical 
components contained in these essential oils have been shown to be effective in 
combating pathogens [34, 35]. Few essential oils have been tested for their antiviral 
activities against food-borne viruses, particularly for HAV [36].
The anti-HAV activity of essential oils obtained from lemon (Citrus limon), 
sweet orange (Citrus sinensis), grapefruit (Citrus paradisi), and rosemary cineole 
(Rosmarinus officinalis) have been reported [33]. Essential oils belonging to the 
genus Citrus contain 85–99% of volatile compounds such as sesquiterpenes, mono-
terpene (limonene), and hydrocarbons, with their oxygenated products including 
aldehydes (citral), acids, ketones, alcohols (linalool), and esters [37]. Rosmarinus 
officinalis of the family, Lamiaceae, is generally applied during the preparation of 
some European cuisine and is also used as a medicinal plant, because of the strong 
antiseptic properties, antibacterial and antioxidant activities of it’s essential oil 
[38]; rosemary oil is also used as a natural food preservative [39, 40].
Essential oil treatment of ATCC/HM-175 strain of HAV propagated in Frp3 cells 
revealed that after an hour incubation at room temperature, the greatest reduction 
in cell infectivity was observed for rosemary cineole EO, followed by grapefruit and 
lemon EOs, while orange EO, although reducing HAV infectivity was not statisti-
cally significant [33]. Orange and grapefruit EOs were found to be cytotoxic for 
Frp3 cells at concentrations that exceeded 0.1%, while lemon and rosemary cineole 
EOs were cytotoxic at concentrations exceeding 0.5% and 0.05%, respectively. 
Studies have also revealed that treatment of contaminated berries with all four 
EOs from lemon, orange, grapefruit and rosemary cineole reduced the viral titer 
of HAV at room temperature. Essential oil from rosemary cineole was shown to be 
the most effective, as it significantly reduced the HAV titer on the berries followed 
by essential oils from grapefruit and lemon respectively [33]. Anti-HAV activity of 
essential oil from orange was not significant though there was a reduction in the 
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HAV titer on the berries. However, application of these essential oils alone may not 
be sufficient to decontaminate soft fruits (berries) laden with higher viral (HAV) 
loads [33]. Therefore, it is imperative that the essential oils be considered for use 
in food sterilization in combination with other treatments. It is also necessary to 
evaluate the minimum time it takes for EOs to reduce the maximum HAV loads 
on food produce so that adequate awareness is made to individuals to achieve food 
product safety before consumption [33]. Moreover, the mechanisms of anti-HAV 
activity of EOs have not yet been elucidated.
2.1.5 Korean red ginseng extract and ginsenosides
Ginseng (Panax ginseng Meyer) is a famous medicinal herb that has been used 
for over 5000 years in Korea and China [41]. Ginseng contains myriad bioactive 
components including, ginsenosides, phytosterols, polysaccharides, polyacetylenes, 
polyacetylenic alcohols, fatty acids and peptides [42]. There exists already docu-
mentations on the anti-stress, anti-carcinogenic, anti-inflammatory, antioxidant, 
anti-bacterial, anti-viral and anti-fungal activities of ginseng [42–44]. Furthermore, 
ginseng demonstrates useful activity on endocrine diseases, cardiovascular diseases 
and the immune system [45]. During processing, Red ginseng is usually steamed 
and fermented with skinned ginseng and this alters the composition saponin 
contained in it when done repeatedly [46]. Red ginseng has been shown to possess 
anti-cancer, anti-diabetic, anti-obesity and immunomodulatory properties [3, 4]. 
Likewise zidovudine, red ginseng has also been applied as a therapeutic supplement 
for the treatment of patients with human immunodeficiency virus [47].
Studies have shown that red ginseng extract and its ginsenosides inactivate food 
borne viruses such as the human norovirus (huNoV) surrogates (feline calicivirus 
and murine norovirus) [43]. A plaque assay performed on FRhK-4 cell lines pre-
treated and co-treated with varied concentrations of Korean red ginseng (KRG) 
extract and purified ginsenosides (Rg1 and Rb1) showed that after inoculation of 
HAV HM-175 strain on the cell lines, KRG and the ginsenosides reduced signifi-
cantly the HAV concentration [3, 4]. Korean red ginseng’s extract demonstrated 
cytotoxicity at concentration above 10 μg/mL, while the purified ginsenosides 
showed no cytotoxic activity even up to 40 μg/mL. Although co-treatment of 
cell lines with KRG and the ginsenosides exhibited significant reduction of HAV 
concentration in the study, anti-HAV activity of the pretreated cell lines was quite 
higher [3, 4]. Hence, pretreatment with ginseng may be effective in preventing 
HAV infection. Also co-treatment of cell lines with KRG and the ginsenosides may 
be evaluated in further study using in vivo models.
The anti-HAV mechanisms of KRG extract and its ginsenosides are not clearly 
defined. However, reports from studies have shown that HAV-infected FRhK-4 cells 
activate the 2′-5′ oligoadenylate synthetase/RNaseL pathway [48]. Activation of 
RNase L degrades viral RNA and cellular single-stranded RNA; hence, KRG extract 
and its ginsenosides may tour a similar path. In addition, previous studies have 
reported that ginseng polysaccharides and ginsenosides have the capacity to boost 
the production of cytokines via stimulation of immune cells [3, 4]. Interferons 
induced by this pathway also contribute to the antiviral response.
2.1.6 Blueberry juice and blueberry proanthocyanidins
Blueberries are said to contain about 88–261 mg of proanthocyanidin/100 g 
of edible portion according to the USDA database for flavonoid content (USDA 
Database for the proanthocyanidin Content of Selected Foods, August 2004). 
Again, blue berries possess some other structurally related polyphenols such as 
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anthocyanins and flavonoids [49]. Blueberry juice and its polyphenols have been 
found to have promising health benefits which include their cardioprotective, neu-
roprotective, anticarcinogenic, antibacterial, and antiviral properties [50]. Ethanol 
and water extracts of blueberries were reported to decrease Listeria monocytogenes 
by 5.90 log CFU/ml at 24 ppm and 37°C after 24 h in-vitro [51]. Also, 0.4 g/L gallic 
acid from blueberries caused a reduction in of E. coli O157:H7 titer in addition to 
the disruption of its cell-membrane after 24 h at 37°C in-vitro [52]. In addition, in a 
hepatitis C virus replicon cell system, methanol extract fraction of blueberry leaves 
(0.112–2200 lg/ml) was shown to suppress hepatitis C virus (HCV) subgenomic 
expression at 37°C after 72 h [53].
Recent study evaluated the antiviral activities of Blueberry juice and its proan-
thocyanidins (B-type) against HAV and some of human norovirus surrogates [50]. 
It was shown that in suspension, HAV titers were reduced by proanthocyanidins (2 
and 5 mg/ml) to undetectable levels after 30 min, and after 3 h by 1 mg/ml proan-
thocyanidins. HAV titer was only reduced to by 2 log PFU/ml with Blue berry juice 
at pH 2.8 and 37°C after 24 h [50]. FRhK4 cells pre-infected and post-infected with 
HAV (strain; HM175) were also investigated for viral adsorption and replication 
upon treatment with the Blueberry juice and isolated proanthocyanidins [50]. The 
Blue berry proanthocyanidins showed promising preventive capacity as it moder-
ately reduced HAV infectivity in the pre-infected cells but did not affect the replica-
tion of HAV in the post-infected cells. Hence, the Blue berry proanthocyanidins 
interrupt HAV binding and entry much more than it can limit its replication in the 
host cells; suggesting that it’s antiviral efficacy is more preventive than therapeutic.
2.1.7 Aqueous extracts of Hibiscus sabdariffa calyces
Hibiscus sabdariffa, belonging to the family, Malvaceae, is an annual tropical or 
subtropical shrub species found in countries including Mexico, Sudan, India, and 
Thailand [54]. It is commonly called ‘roselle’ and is used for ornamental purposes, 
and the red calyces of H. sabdariffa are often used in the preparation of cold or hot 
beverages [55]. The calyces are said to be rich in bioactive compounds like antho-
cyanins, saponins, phenolic acids, organic acids and alkaloids [56]. Presence of 
organic acids like malic and tartaric acids identified in the calyces, possess a low pH 
of approximately 2–2.5 [54]. Aqueous extracts of the calyces are considered gener-
ally as safe and are approved for use as food additives by the U.S. Food and Drug 
Administration (21 CFR 172.510) in the flavoring of beverages [22, 23]. The calyces 
of H. sabdariffa are reported to possess a wide range of health benefits including 
antioxidant, anticancer, cardioprotective, anti-diabetic, and antimicrobial effects 
[57–59]. Protocatechuic acid (PCA), an essential component of H. sabdariffa has 
been shown to be the component responsible for its antimicrobial activity [60]. 
Another chemical component of the genus Hibiscus, known as Ferulic acid (FA) 
has also been reported to exhibit antimicrobial properties and antifilarial activity 
against Setaria cervi [61, 62].
Recent study evaluated the antiviral activity of H. sabdariffa against human 
novovirus surrogates and HAV. Findings revealed that aqueous extracts of calyces 
of H. sabdariffa (100 and 40 mg/ml) reduced HAV titer in suspension to undetect-
able levels at 37°C after 24 h [22, 23]. However, PCA demonstrated a moderate 
antiviral effect on HAV as it significantly reduced the HAV titer in suspension but 
not to undetectable levels. Pre- and post-infection assays with the aqueous extract 
of the calyces of H. sabdariffa (5 mg/ml) demonstrated no notable change in titres 
observed for HAV [22, 23]. Higher concentrations (40 and 100 mg/ml) of the 
aqueous extract was found to be cytotoxic to the host cell lines when added; obser-
vation for visual cytopathic effect under the light microscope showed that cells were 
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peeling off [22, 23]. It is likely the aqueous extract is effective for alleviating viral 
burden; however this has not yet been substantiated as more studies into model 
food systems and simulation of gastrointestinal tract conditions to test the efficacy 
of the extracts under in vivo conditions are required.
2.1.8 4-phenylcoumarin derivatives
Coumarin was first isolated from tonka beans, Dipteryx odoranta, also called 
Coumarou and biological activities of thousands of natural coumarins from plants, 
bacteria and fungi and chemical synthesis have been reported [63]. Coumarin 
and its derivatives have been used to manufacture drugs serving as anticoagulants 
including warfarin, acenocoumarin and phenprocoumon, and also for produc-
tion of novobiocin, a potent inhibitor of bacterial DNA gyrase [63]. Coumarins 
(2H-chromen-2-ones) are recognized as a privileged bioactive scaffold for design-
ing new agents with high affinity and specificity to various molecular targets [64], 
especially as antiviral agents [65]. In recent years, 4-Phenylcoumarins (neofla-
vones) which are bio-isosteres of flavonoids, have been of much interest as lead 
target structure for the discovery of new antiviral agents [66, 67].
A more recent study demonstrated that some coumarin derivatives possess 
anti-HAV activity. Newly modified 4-phenylcoumarin-based compounds were 
developed and evaluated for inhibition of 3C proteases [63]. Similar to other 
picornaviruses, HAV genome encodes a key processing protease, known as HAV 
3C protease (HAV 3Cpro), which is a nonstructural cysteine protein responsible for 
the cleavage process within the viral polyprotein (250 kDa) that is critical for the 
replication process [63]. These proteases are responsible for processing the poly-
protein precursor and also cleaving specific cellular factors needed for transcription 
and translation processes as well as nucleo-cytoplasmic trafficking in order to alter 
cell physiology to enhance viral replication; thus 3Cpro is vital to viral life cycle, 
making the viral 3C proteases choice targets for antiviral therapy [63]. Evaluation of 
the target compounds for their antiviral activity against hepatitis A virus revealed 
that the derivative, 1-(2-(2-Oxo-4-phenyl-2H-chromen-7-yloxy)acetyl) 4-ethylthi-
osemicarbazide had the most potent virucidal activity (IC50 = 3.1 μg/ml, TI = 83). 
The derivatives, 2-(2-Oxo-4-phenyl-2H-chromen-7-yloxy)-N′-(1-(4-chlorophenyl)
ethylidene)acetohydrazide and 2-(2-Oxo-4-phenyl-2H-chromen-7-yloxy)-N′-(1-
(4-bromophenyl)ethylidene)acetohydrazide demonstrated the strongest virustatic 
effects against HAV adsorption and replication, respectively (IC50 = 8.5 μg/ml, 
TI =88; IC50 = 10.7 μg/ml, TI = 91). Furthermore, studies reported that the three 
newly derived compounds were tested against HAV 3C protease and they exhibited 
remarkable inhibition effects (Ki = 1.903, 0.104 and 0.217 μM, respectively) indi-
cating strong binding to HAV 3Cpro [63]. Also, the three compounds were docked 
within the pocket site of HAV 3C protease (PDB code: 2HAL) which illustrated 
that they had strong H-profiles with the amino acids Gly170 and Cys172. Findings 
suggested that the target compounds inhibited virus infection through the inter-
rupting virus adsorption to the cell surface. This may have occurred via blocking of 
the cellular surface receptors by the target compounds which consequently led to an 
anti-HAV effect. Deduction from the post-treatment assay suggested that the target 
compounds inhibited the activities of some viral enzymes needed to complete the 
replication cycle or that they interfered with one or more steps in the viral life cycle.
2.1.9 Protamine, taxifolin and atropine
Protamine, a cationic peptide, is generally obtained from fish milt (spermatic 
cells) and is applied medically as a heparin antagonist, an injectable insulin-carrier, 
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and recently as an antibacterial ingredient in some food products [68]. Taxifolin 
(dihydroquercetin) is a flavononol amply found in grapes, olive oil, citrus fruits and 
onions [69]. It has been shown to possess strong pharmacological activities, includ-
ing antioxidative, hepatoprotective, cardioprotective, anti-diabetic, anti-inflam-
matory, antitumor, neuroprotective effects, and had played a remarkable role in the 
preclusion of Alzheimer’s disease [69]. Atropine is naturally occurring compound 
(alkaloid) majorly found in belladonna (Solanaceae) plants. It is a muscuranic 
receptor antagonist and is used medically to modulate muscular contractions and 
dilations which consequently regulate blood flow to cells and tissues [70].
A previous study investigated the inhibitory potential of protamine, atropine 
and taxifolin against HAV replication in PLC/PRF/5 cells, and found out that the 
trio exhibited some significant but not drastic effects on HAV replication [2]. 
Atropine demonstrated a concentration–dependent reduction in the infectivity of 
HAV but the antigenicity of the virus was not affected. HAV titer was reduced at 
the maximum concentration of 50, 59 and 50 μg/ml of protamine, taxifolin and 
atropine, respectively. It was suggested that further studies be done to determine 
the effect of these compounds on several multiplicities of HAV infection and also 
investigate possible synergistic effects of these compounds with other substances 
that have potential for clinical use against HAV infection [2]. The mechanisms of 
HAV titer reduction by the compounds are not yet clearly elucidated.
3. Adjunctive anti-HAV natural products
3.1 Japanese rice-koji miso extracts
Koji, also known as Aspergillus oryzae, is a filamentous fungus employed by the 
Japanese to ferment certain kinds of food like soybeans, potatoes, rice and some 
other grains [71]. Miso is one of the by-products of the fermentation of Japanese 
rice by Koji. Miso is conventional Japanese seasoning used for preparing miso soup, 
a staple Japanese cuisine [71]. Previous studies showed that Japanese miso extract 
increases the expression of a heat-shock protein known as glucose-regulated protein 
78 (GRP78) and suppresses ultraviolet C mutagenesis [72]. Some researchers 
observed that HAV replication was retarded upon expression of GRP78 [71]; hence 
GRP78 has become a potential host antiviral against HAV infection [73]. Recent 
post-infection assay examined miso extracts obtained from Japanese rice-koji for 
antiviral activity against HAV, and it was shown that the miso extracts inhibited 
HAV replication by enhancing the expression of GRP78 in human hepatocytes 
(Huh7 and PXB cells) [71]. These findings suggested that Japanese miso extracts 
may synergistically work as antivirals against HAV infection by partially modulat-
ing GRP78 expression [71]. Miso extracts may also serve as effective dietary supple-
ments for the control of acute hepatitis A infection.
3.2 Korean soy sauce
Conventional Korean soy sauce is generally made with germinated soybean, salt 
and water [74]. The soy sauce is fermented after cooking and crushing soybean, 
then mold it into a block form (Meju) with concurrent addition of salt (NaCl) and 
water before exposing it to natural conditions [3, 4]. The percentage salt content of 
traditional Korean soy sauce is around 16.3–20.8% NaCl [75]. Studies have shown 
that soy sauce possesses diverse biological activities such as angiotensin inhibitory, 
anti-platelet, anticarcinogenic, and anti-oxidant activities [74]. Also, there is a report 
about the antibacterial activity of soy sauce against Escherichia coli O157:H7 [76]. The 
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antimicrobial effects of soy sauce were attributed to the presence of a combination of 
ingredients and properties including NaCl, ethanol, pH, organic acids, and preserva-
tives [74].
A study that evaluated the antiviral activity of the Korean soy sauce on HAV 
inoculated in raw fresh crabs (Portunus trituberculantus) to simulate storage condi-
tions for homemade Ganjanggejang (a salted preserved raw seafood in Korean 
cuisine) revealed that there was an over 90% reduction of the HAV titer in the 
Ganjanggejang marinated in soy sauce containing 20% NaCl for at least 3 days 
[74]. Hence, the soy sauce was synergistically more effective at increasing salt 
concentrations. The antiviral activity of soy sauce is majorly due to the salt (NaCl) 
concentrations and partially attributable to its other constituents, such as ethanol, 
organic acids, and preservatives, and the pH of 5.11–6.98 [77]. Inhibition of HAV 
in crabs by NaCl in soy sauce might be due to changes in water activity which may 
affect virus survival [77]. In addition, antiviral mechanisms associated with NaCl 
may include altering the molecular structure of the viral RNA and inhibiting the 
viral enzymes’ activity [74]. However, it’s not likely that Korean soy sauce will be 
of relevance in clinical practice rather it may be instrumental for immediate food 
preservation and storage before consumption (Table 1).
Evaluated natural 
products
Concentration Result Proposed 
mechanism of 
action
References
Green Tea Extract 5 mg/ml for 2 h 
at 37°C and pH 
of 7.2
Complete 
inactivation of 
HAV in suspension
Interfers with viral 
attachment to cell 
membrane receptors 
upon binding to 
them
[7, 15]
Grape Seed 
Extract
2 mg/ml for 6 h 
at 37°C
Reduced HAV titer 
to undetectable 
levels under 
simulated 
gastrointestinal 
conditions
Interrupt the binding 
of HAV to the cell 
receptors, preventing 
adsorption.
[23, 24, 28]
Egyptian Red Sea 
Seagrass Crude 
Extract
20 μg/mL 100% inhibition 
of HAV in a plaque 
assay
— [28]
Essential Oils 
(EO) from lemon, 
grapefruit and 
rosemary cineole
0.1% (EO from 
grapefruit); 
0.5% (EO 
from lemon); 
0.05% (EO 
from rosemary 
cineole)
Significant 
reduction in 
cell infectivity 
in the order; 
rosemary cineole > 
grapefruit > lemon.
— [33]
Korean Red 
Ginseng Extract 
and Ginsenosides
5–10 μg/mL 
For 24 h at 
37°C
Significant 
reduction of HAV 
titer with dose-
dependent manner 
in pretreated 
FRhk-4 cells
(1) Activation of the 
2′-5′oligoadenylate 
synthetase/RNaseL 
pathway;
(2) boost the 
production of 
cytokines
[3–5, 49]
Blueberry Juice pH 2.8 at 37°C 
for 24 h
Reduced HAV titer 
by 2 log PFU/ml
Interfers with HAV 
binding to host cells
[50]
Blueberry 
Proanthocyanidins
2 and 5 mg/ml 
for 30 min at 
37°C
Reduced HAV titer 
to undetectable 
levels in suspension
Interrupt HAV 
binding and entry 
into host cells
[50]
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4. Miscellaneous products
Duck hepatitis A virus type-1(DHAV-1) is a variant of hepatitis A virus that 
attacks ducks. It has been proposed that duck hepatitis A is a small animal model 
for the human hepatitis A [78]. It may be correct to say that antiviral agents against 
DHAV-1 will also demonstrate appropriate antiviral activity against human hepati-
tis A virus. Several natural agents have been under study to explore their antiviral 
potentials against DHAV-1 and they include phosphorylated Codonopsis pilosula 
polysaccharide (pCPP), Raw Rehmannia Radix Polysaccharide (RRRP), Baicalin 
phospholipid complex (BAPC), flavonoid combinations—baicalin-linarin-icariin-
notoginsenosideR1 (BLIN).
It was reported that RRRP could significantly reduce mortality rate, liver 
lesion scoring, alleviate visual liver lesion, and decrease the alterations of plasma 
biochemical evaluation indexes of hepatic injury induced by DHAV-1 infection 
[79]. pCPP was also reported to demonstrate a strong inhibitory effect on DHAV-1 
replication, which led to a significant decrease on the number of viral particles [80]. 
Studies with DHAV-1-infected ducklings treated with BAPC showed that it signifi-
cantly inhibited DHAV-1 adsorption, replication and release [81]. Furthermore, it 
was reported that BAPC played anti-oxidative and immuno-supportive roles during 
the treatment, and that the immuno-supportive role was critical to the treatment. 
Another study evaluated the anti-DHAV-1 activity of a flavonoid mix, BLIN [82]. 
At 20 μg/mL, DHAV-1 inhibitory rate of BLIN at 20 μg/mL was reported to be 
69.3% in duck embryonic hepatocytes. It was demonstrated that the survival rate 
of ducklings treated by BLIN was about 35.5%, which was remarkably higher than 
that of virus control (0.0%) [82]. In addition, after the treatment with BLIN, both 
Evaluated natural 
products
Concentration Result Proposed 
mechanism of 
action
References
Aqueous extracts 
of Hibiscus 
sabdariffa Calyces
100 mg/ml and 
40 mg/ml at 
37°C for 24 h
Reduced HAV titer 
to undetectable 
levels in suspension
— [22, 23]
4-phenylcoumarin 
derivatives
10 μl at 37°C Inhibited the 
activity of HAV 3C 
protease
Interrupt HAV 
adsorption on cell 
surface
[63]
Protamine 50 μg/ml Reduced HAV 
infectivity
— [2]
Taxifolin 59 μg/ml Reduced HAV 
infectivity
— [2]
Atropine 50 μg/ml Reduced HAV 
infectivity
— [2]
Japanese rice-koji 
miso extracts
— Inhibited HAV 
replication
Inhibited HAV 
replication by 
enhancing the 
expression of 
GRP78 in human 
hepatocytes
[71]
Korean Soy Sauce Containing 
20% NaCl
over 90% 
reduction of the 
HAV titer
Inhibition of viral 
enzymes’ activity
[74]
Table 1. 
Summary of anti-HAV natural products.
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the hepatic injury and the oxidative stress of the infected ducklings assuaged [82]. 
Concurrently, a significant positive correlation was said to exist between the hepatic 
injury indices and the oxidative stress indices.
5. Future outlook
Currently, studies exploring potential anti-HAV natural products are still 
emerging and had attracted little attention, possibly because a vaccine has been 
developed to mitigate the spread of the viral infection to a considerable length 
of years. However, there is need for development of more efficient and effective 
anti-HAV therapeutic, prophylactic and adjunctive agents, and as at now, none has 
been licensed. Investigations into natural products with anti-HAV hold a promis-
ing outlook as several of them have demonstrated remarkable potential to control 
HAV infection and replication. In addition, studies should be aimed at mimicking 
more closely the features of the human hepatitis A virus in vivo than in vitro so as to 
clearly establish the basis for the application of these natural agents in a clinical set-
ting. There is need to develop suitable animal models that could present very similar 
clinical manifestations as found in humans during hepatitis A virus infection, for 
more accurate interpretation and correlation of outcomes from pre-clinical studies 
involving natural products therapy. Hopefully, studies on antiviral natural products 
against HAV will gain ample attention in the nearest future.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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